Condition: Ventricular Arrhythmias and Cardiac Arrest · Sponsor: Versailles Hospital
To determine if prophylactic administration of amiodarone for 72 hours in critically ill patients admitted after an OHCA with shockable rhythm, with a confirmed or a presumed cardiac cause, decreases the incidence of a composite endpoint of 30-day (starting from inclusion) all-cause mortality and/or severe in-hospital ventricular arrhythmia recurrence (ventricular fibrillation and/or ventricular tachycardia requiring intervention including re-arrest)
This description comes directly from the study's public registry record.
Sandrine Roux · 0139239777 · sroux@ght78sud.fr
Always discuss trial participation with your own doctor first.
| Chu Amiens | Amiens, France | Not Yet Recruiting |
| Chu Angers | Angers, France | Recruiting |
| CH annecy genevois | Annecy, France | Recruiting |
| Ch Argenteuil | Argenteuil, France | Recruiting |
| CH Mondor | Aurillac, France | Recruiting |
| CHU Brest | Brest, France | Recruiting |
| CH Brive | Brive-la-Gaillarde, France | Recruiting |
| Chu Caen | Caen, France | Not Yet Recruiting |
| Chi Nord Ardennes | Charleville-Mézières, France | Recruiting |
| CHSF | Corbeil-Essonnes, France | Recruiting |
| CHD vendée | La Roche-sur-Yon, France | Recruiting |
| CH la rochelle | La Rochelle, France | Recruiting |
+ 17 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06835491